Smith & Nephew (SNN) return on equity (ROE)

Return on equity · fiscal 2025
11.8%

Smith & Nephew (SNN) earned a return on equity of 11.8% in fiscal 2025 (the year ended December 31, 2025). That is 4.0 percentage points higher than the 7.8% of fiscal 2024. Figures as of 17 Nov 2026, 22:22 UTC, from Yahoo Finance.

Key facts

Return on equity, fiscal 2025
11.8%
Change on fiscal 2024
+4.0 pts
Highest on record
11.8%fiscal 2025
Lowest on record
4.2%fiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Smith & Nephew return on equity (ROE), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 11.8% in fiscal 2025 and the lowest 4.2% in fiscal 2022. The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 5.0%.

History · 4 fiscal years

Return on equity by fiscal year

Smith & Nephew return on equity (ROE), year by year

Smith & Nephew (SNN) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202511.8% 4.0 pts up
20247.8% 2.8 pts up
20235.0% 0.8 pts up
20224.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Smith & Nephew and comparable companies
CompanyReturn on equityFiscal year
BrightSpring Health Services BTSG10.2%2025
Baxter International BAX-15.6%2025
Elanco Animal Health ELAN-3.5%2025
Smith & Nephew SNN11.8%2025
Penumbra PEN12.4%2025
Dr. Reddy's Laboratories RDY11.4%2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SNN

Smith & Nephew, figure by figure

Smith & Nephew (SNN) overview: price, valuation and scorecardAll health care companies by market value

Smith & Nephew return on equity (ROE): questions and answers

What is Smith & Nephew's return on equity?

Smith & Nephew (SNN) earned a return on equity of 11.8% in fiscal 2025 (the year ended December 31, 2025). That is 4.0 percentage points higher than the 7.8% of fiscal 2024.

Is Smith & Nephew's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 5.0%.

What are the highest and lowest return on equity figures on record for Smith & Nephew?

Across the 4 fiscal years on record (2022–2025), the highest was 11.8% in fiscal 2025 and the lowest 4.2% in fiscal 2022.

How is Smith & Nephew's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Smith & Nephew (SNN) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/SNN/roe

Underlying data: Yahoo Finance.